tiprankstipranks
Trending News
More News >
PMGC Holdings (ELAB)
NASDAQ:ELAB
US Market
Advertisement

PMGC Holdings (ELAB) Price & Analysis

Compare
283 Followers

ELAB Stock Chart & Stats


PMGC Holdings News

ELAB FAQ

What was PMGC Holdings’s price range in the past 12 months?
PMGC Holdings lowest stock price was $4.29 and its highest was $899.36 in the past 12 months.
    What is PMGC Holdings’s market cap?
    PMGC Holdings’s market cap is $2.47M.
      When is PMGC Holdings’s upcoming earnings report date?
      PMGC Holdings’s upcoming earnings report date is Dec 15, 2025 which is in 84 days.
        How were PMGC Holdings’s earnings last quarter?
        PMGC Holdings released its earnings results on Aug 13, 2025. The company reported -$1.583 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.583.
          Is PMGC Holdings overvalued?
          According to Wall Street analysts PMGC Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does PMGC Holdings pay dividends?
            PMGC Holdings does not currently pay dividends.
            What is PMGC Holdings’s EPS estimate?
            PMGC Holdings’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does PMGC Holdings have?
            PMGC Holdings has 424,236 shares outstanding.
              What happened to PMGC Holdings’s price movement after its last earnings report?
              PMGC Holdings reported an EPS of -$1.583 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.222%.
                Which hedge fund is a major shareholder of PMGC Holdings?
                Currently, no hedge funds are holding shares in ELAB

                Company Description

                PMGC Holdings

                PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.

                PMGC Holdings (ELAB) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                TNF Pharmaceuticals
                Scinai Immunotherapeutics
                Entero Therapeutics
                Protagenic Therapeutics
                ZyVersa Therapeutics

                Ownership Overview

                25.70%0.82%74.30%
                25.70% Insiders
                0.82% Other Institutional Investors
                74.30% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis